A 38-year-old woman with major depressive disorder is started on sertraline 50 mg daily. After 3 weeks, she reports persistent depressive symptoms with no improvement. Her psychiatrist suspects sertraline non-response and wants to confirm adequate drug exposure before switching to another agent. Which investigation is most appropriate to guide the next therapeutic decision?